The real-world effectiveness of sucroferric oxyhydroxide in European hemodialysis patients: a 1-year retrospective database analysis
Rosa Ramos(NephroCare), Stefano Stuard(Fresenius Medical Care (United States)), Sebastian Walpen(Vifor Pharma (Switzerland)), Astrid Feuersenger(Fresenius Medical Care (Germany)), Konstantin Gurevich, Melanie Wolf(Fresenius Medical Care (Germany)), Hans‐Jürgen Arens(Fresenius Medical Care (Germany)), Charles Chazot(Clinique Charcot), Attilio Di Benedetto, Aníbal Ferreira(Hospital Vila Franca de Xira)
Cited by 6
Related Papers
Survival as an index of adequacy of dialysis
|Kidney International|1992|769
Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population
|Nephrology Dialysis Transplantation|2010|478
Chronic Fluid Overload and Mortality in ESRD
|Journal of the American Society of Nephrology|2017|407
Vitamin D in Chronic Kidney Disease and Dialysis Patients
|Nutrients|2017|361
Importance of normohydration for the long-term survival of haemodialysis patients
|Nephrology Dialysis Transplantation|2012|225